Formulation & R&D (F&D)

Advanced tablet technologies incorporating physical barriers (ultra-high molecular weight PEO resisting crushing), gelling agents, or sequestered opioid antagonists (Naloxone).

Antibodies engineered to lack fucose on core N-glycans, dramatically increasing binding affinity to Fc-gamma-RIIIa receptors.

Immune mechanism where antibody Fc domain binds Fc-gamma-RIIIa on Natural Killer (NK) cells, triggering target cell lysis.

Empirical principle stating that the phase in which an emulsifier is more preferentially soluble constitutes the continuous external phase of the emulsion.

High solubility and high intestinal permeability drug substance.

Low solubility and high intestinal permeability drug substance.

High solubility and low intestinal permeability drug substance.

Low solubility and low intestinal permeability drug substance.

The propensity of compressed tablets to separate horizontally at the top crown during or immediately following ejection from the die.

Lipid-based self-emulsifying surfactant and intestinal permeability enhancer (HLB 12).

Positively charged bio-polymeric nanoparticles prepared by ionic gelation of chitosan with tripolyphosphate (TPP).

Effector mechanism where antibody Fc binds complement component C1q, triggering complement cascade and membrane attack complex lysis.

Vinylpyrrolidone-vinyl acetate (60:40) copolymer used in hot-melt extrusion and dry binder compaction.

Composite mixture of two or more compendial excipients physically combined at sub-particle level via spray drying or co-precipitation.

The narrow concentration range of surfactant in water above which surfactant monomers spontaneously self-assemble into thermodynamic micelles.

Insoluble cross-linked synthetic polyvinylpyrrolidone acting as a superdisintegrant via rapid water wicking and strain recovery.

Cone-shaped cyclic oligosaccharides (alpha, beta, gamma, HP-beta-CD, Captisol) with hydrophilic outer surface and lipophilic central cavity.

Multidimensional combination and interaction of input variables (material attributes and process parameters) demonstrated to assure quality.

High-purity pharmaceutical hydrophilic penetration enhancer and powerful solubilizing solvent for topical and oral drugs.

Synthetic saturated phospholipid with 16-carbon acyl chains (Tm ~41 deg C) mimicking endogenous lung surfactant.

Specially engineered spray-dried or agglomerated excipient exhibiting plastic deformation and free-flowing properties.

Specially co-processed or spray-dried excipients (e.g. Microcrystalline Cellulose Avicel PH-102, Spray-Dried Lactose Fast-Flo) possessing high fluidity and compressibility.

Synthetic saturated phospholipid with 18-carbon acyl chains and high phase transition temperature (Tm ~55 deg C).

Ratio of total concentration of all species (both ionized and un-ionized) of a compound in octanol versus aqueous buffer at specified pH.

Unintended rapid premature release of the entire drug dose from an extended-release dosage form into the body.

Formulation where micronized active drug crystals (1-5 um) are blended onto the surface of coarse alpha-lactose monohydrate carrier particles (50-100 um).

Uncoated tablets containing an organic acid (Citric or Tartaric acid) and a carbonate salt (Sodium Bicarbonate) that react in water to release carbon dioxide gas.

Comprehensive inspection summary written by USFDA investigators following an on-site audit of a domestic or foreign pharmaceutical manufacturing facility.

Mixture of two or more solid components that liquefies or melts at a temperature lower than the melting point of any individual component.

Inactive substance formulated alongside the active pharmaceutical ingredient for bulking, stability, or drug absorption.

Continuous pharmaceutical process mixing and melting API with thermoplastic polymers (e.g. Soluplus, Kollidon VA64) through heated twin-screws.

Polymer with acetyl and succinoyl groups widely utilized as carrier in spray-dried amorphous dispersions.

Modern Karl Fischer titration reagents replacing toxic pyridine with non-hazardous organic bases (such as imidazole or diethanolamine) with faster reaction rates.

Kinetic solubility measures the concentration when a precipitate first appears upon adding drug dissolved in organic solvent into aqueous buffer; thermodynamic solubility is equilibrium solubility of crystalline drug after 24-48 hours.

Natural disaccharide crystalline diluent extensively used in tablet and capsule formulations due to its inertness, water solubility, and excellent compressibility.

Semi-solid self-emulsifying excipient with melting point 44 deg C and HLB 14.

Sub-100 nm spherical vesicles composed of ionizable cationic lipids, helper phospholipids, cholesterol, and PEGylated lipids encapsulating mRNA therapeutics.

Transmembrane pH or electrochemical gradient across liposome bilayers driving uncharged amphiphilic weak bases into the aqueous core where they become protonated and trapped.

Spherical vesicles composed of concentric phospholipid bilayers enclosing an internal aqueous core, mimicking biological cell membranes.

Fruit acid used as buffering agent, flavor enhancer, and acidulant in chewable and effervescent tablets.

Locally acting anti-inflammatory drug for ulcerative colitis formulated with pH-dependent enteric coats (Eudragit S100 dissolving at pH >= 7.0) or semipermeable ethylcellulose micropellets.

Phospholipid conjugated to 2,000 Da polyethylene glycol chain imparting steric stealth properties to nanoparticles.

Hydrophilic synthetic or natural polymers (carbomer, chitosan, sodium alginate) binding to mucosal epithelial mucin glycoproteins.

Technique visualizing and analyzing particles in liquids by relating Brownian motion rate to hydrodynamic diameter via the Stokes-Einstein equation.

Second-generation lipid nanoparticles composed of spatially incompatible solid and liquid lipid blends forming a disorganized matrix.

Ultra-high-potency synthetic derivative of aspartame approximately 7,000 to 13,000 times sweeter than sucrose.

The displacement of atmospheric air inside manufacturing compounding vessels with a continuous blanket of high-purity, sterile-filtered inert nitrogen gas.

Purified soybean lecithin containing >= 90% phosphatidylcholine, used in liposomes and parenteral lipid emulsions.

Amphiphilic block copolymer aggregates (e.g. PEG-PLA) with hydrophobic core encapsulating lipophilic drugs and hydrophilic outer corona.

Water-soluble excipient (e.g. PEG, sodium chloride, lactose) incorporated into insoluble polymer coating films.

Lipophilic water-insoluble surfactant (HLB 5-6) used as primary oily oil phase in self-emulsifying drug systems.

A systematic, science- and risk-based development approach beginning with predefined objectives and emphasizing product and process understanding based on sound science and quality risk management.

Submicron colloidal carriers composed of physiological lipids (triglycerides, waxes) that remain solid at room and body temperature.

Liquid self-emulsifying isotropic blends transformed into dry free-flowing powders by adsorption onto high-surface-area porous carriers.

Rapid thermodynamic evaporation of atomized liquid droplets into fine dry powders in a heated drying gas stream (nitrogen/air).

Nanocarriers coated with surface-grafted Polyethylene Glycol (mPEG-DSPE) chains creating a steric hydration barrier that prevents plasma opsonization.

Waxy self-emulsifying carrier with melting point ~50 deg C and HLB 13, creating immediate-release solid dispersions.

High-intensity chlorinated disaccharide sweetener approximately 600 times sweeter than sucrose.

Hydraulic pressure generated inside a tablet matrix as superdisintegrant particles rapidly absorb water and expand in volume.

Cross-linked 3D hydrophilic polymer network absorbing water to form a viscous gel that controls drug diffusion over extended periods.

Water-soluble organic acid paired with citric acid and sodium bicarbonate in balanced effervescent granules.

Aqueous polymer solutions (e.g. Poloxamer 407) that remain liquid at room temperature (20 deg C) but undergo sol-gel transition at body temperature (37 deg C).